Difficulty: Medium
Average Score: 69%
Practice
Non-selective ß-blockers are contraindicated in:
Correct answer
C
Rationale
The correct answer is C) Peripheral vascular disease.
Non-selective ß-blockers block both ß1 and ß2 adrenergic receptors, leading to potential vasoconstriction in peripheral blood vessels. In patients with peripheral vascular disease, where there is already compromised blood flow to the extremities, the vasoconstrictive effect of non-selective ß-blockers can exacerbate the condition by further reducing blood flow.
Option A) Angina of effort: Non-selective ß-blockers are commonly indicated in angina of effort due to their ability to reduce myocardial oxygen demand by decreasing heart rate and contractility.
Option B) Systemic hypertension: Non-selective ß-blockers are often used to manage systemic hypertension by reducing cardiac output and renin-angiotensin-aldosterone system activation.
Option D) Thyrotoxicosis: Non-selective ß-blockers can be beneficial in managing symptoms of thyrotoxicosis such as tachycardia and tremors by blocking the effects of excess thyroid hormones on the heart and peripheral vasculature.
Educationally, understanding the contraindications of medications is crucial for clinical decision-making to ensure optimal patient outcomes. It is essential for healthcare professionals to be aware of the specific conditions in which certain medications should be avoided to prevent potential harm to patients.
Non-selective ß-blockers block both ß1 and ß2 adrenergic receptors, leading to potential vasoconstriction in peripheral blood vessels. In patients with peripheral vascular disease, where there is already compromised blood flow to the extremities, the vasoconstrictive effect of non-selective ß-blockers can exacerbate the condition by further reducing blood flow.
Option A) Angina of effort: Non-selective ß-blockers are commonly indicated in angina of effort due to their ability to reduce myocardial oxygen demand by decreasing heart rate and contractility.
Option B) Systemic hypertension: Non-selective ß-blockers are often used to manage systemic hypertension by reducing cardiac output and renin-angiotensin-aldosterone system activation.
Option D) Thyrotoxicosis: Non-selective ß-blockers can be beneficial in managing symptoms of thyrotoxicosis such as tachycardia and tremors by blocking the effects of excess thyroid hormones on the heart and peripheral vasculature.
Educationally, understanding the contraindications of medications is crucial for clinical decision-making to ensure optimal patient outcomes. It is essential for healthcare professionals to be aware of the specific conditions in which certain medications should be avoided to prevent potential harm to patients.